Is NF-κB predictive of biochemical recurrence in positive-margin prostate cancer?

被引：0
|
作者：
Carsten Stephan
Glen Kristiansen
Klaus Jung
机构：
[1] Biomarkers of Prostate Cancer Group at the University Hospital Charité,
[2] Humboldt University Berlin,undefined
[3] Department of Urology,undefined
[4] Research Division,undefined
[5] Pathological Institute and supervises the Immunohistochemical Laboratory,undefined
来源：
Nature Clinical Practice Urology | 2005年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：134 / 135
页数：1
相关论文
共 50 条
  • [21] IMMUNOHISTOCHEMICAL ERG STATUS IS NOT PREDICTIVE FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY WITH POSITIVE SURGICAL MARGIN
    Rennau, Michael Ladurner
    Klocker, Helmut
    Heidegger, Isabel
    Skardski, Viktor
    Schaefer, Georg
    Horninger, Wolfgang
    Bektic, Jasmin
    Bektic, Jasmin
    JOURNAL OF UROLOGY, 2013, 189 (04): : E611 - E611
  • [22] Biochemical recurrence of prostate cancer
    不详
    CURRENT PROBLEMS IN CANCER, 2003, 27 (05) : 243 - 272
  • [23] Activated NF-κB in colorectal cancer:: Predictive or prognostic factor?
    Brandi, Giovanni
    Pantaleo, Maria A.
    Biasco, Guido
    Paterini, Paola
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) : 1388 - 1389
  • [24] Impact of international variation of prostate cancer on a predictive nomogram for biochemical recurrence in clinically localised prostate cancer
    Cho, Yong Mee
    Jung, Soo Jin
    Cho, Namhoon
    Kim, Min-ju
    Kattan, Michael W.
    Yu, Changhong
    Ahn, Hanjong
    Ro, Jae Y.
    WORLD JOURNAL OF UROLOGY, 2014, 32 (02) : 399 - 405
  • [25] Impact of international variation of prostate cancer on a predictive nomogram for biochemical recurrence in clinically localised prostate cancer
    Yong Mee Cho
    Soo Jin Jung
    Namhoon Cho
    Min-ju Kim
    Michael W. Kattan
    Changhong Yu
    Hanjong Ahn
    Jae Y. Ro
    World Journal of Urology, 2014, 32 : 399 - 405
  • [26] NF-κB Gene Signature Predicts Prostate Cancer Progression
    Jin, Renjie
    Yi, Yajun
    Yull, Fiona E.
    Blackwell, Timothy S.
    Clark, Peter E.
    Koyama, Tatsuki
    Smith, Joseph A., Jr.
    Matusik, Robert J.
    CANCER RESEARCH, 2014, 74 (10) : 2763 - 2772
  • [27] NF-κB as a prognostic marker and therapeutic target in prostate cancer
    Vykhovanets, Eugene
    Shankar, Eswar
    Shukla, Sanjeev
    Vykhovanets, Olena
    MacLennan, Gregory T.
    Gupta, Sanjay
    CANCER RESEARCH, 2015, 75
  • [28] PROSTATE CANCER < 2 CELLS FROM THE SURGICAL MARGIN PREDICTS BIOCHEMICAL RECURRENCE
    Izard, Jason P.
    True, Lawrence D.
    May, Philip C.
    Ellis, William J.
    Lange, Paul H.
    Lin, Daniel W.
    Wright, Jonathan L.
    JOURNAL OF UROLOGY, 2012, 187 (04): : E663 - E663
  • [29] Risk of biochemical recurrence and timing of radiotherapy in pT3a N0 prostate cancer with positive surgical margin
    Hegemann, Nina-Sophie
    Morcinek, Sebastian
    Buchner, Alexander
    Karl, Alexander
    Stief, Christian
    Knuechel, Ruth
    Corradini, Stefanie
    Li, Minglun
    Belka, Claus
    Ganswindt, Ute
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (07) : 440 - 448
  • [30] Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin - A multicenter study
    Karl, Alexander
    Buchner, Alexander
    Tympner, Christiane
    Kirchner, Thomas
    Ganswindt, Ute
    Belka, Claus
    Ganzer, Roman
    Wieland, Wolf
    Eder, Fabian
    Hofstaedter, Ferdinand
    Schilling, David
    Sievert, Karl-Dietrich
    Stenzl, Arnulf
    Scharpf, Marcus
    Fend, Falko
    vom Dorp, Frank
    Ruebben, Herbert
    Schmid, Kurt Werner
    Porres-Knoblauch, Daniel
    Heidenreich, Axel
    Hangarter, Birgit
    Knuechel-Clarke, Ruth
    Rogenhofer, Michael
    Wullich, Bernd
    Hartmann, Arndt
    Comploj, Evi
    Pycha, Armin
    Hanspeter, Esther
    Pehrke, Dirk
    Sauter, Guido
    Graefen, Markus
    Gratzke, Christian
    Stief, Christian
    Wiegel, Thomas
    Haese, Alexander
    RADIOTHERAPY AND ONCOLOGY, 2015, 116 (01) : 119 - 124
12345